News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Richard Hovis: Join Sean in his battle against Metastatic high risk recurrent Medulloblastoma
Richard Hovis/Bluesky
Dec 30, 2024, 19:58

Richard Hovis: Join Sean in his battle against Metastatic high risk recurrent Medulloblastoma

Richard Hovis shared a post on Bluesky:

“As the year comes to a close let your heart open and join Sean in his battle against Metastatic high risk recurrent Medulloblastoma.”

Support Sean’s Fight against Brain Cancer

cancer cancer caregiver medulloblastoma OncoDaily Oncology Richard Hovis
Special Coverage
Oncolibrary
Aug 17, 2025, 01:33
10 Must-Read Posts in Immuno-Oncology This Week
Insight
Aug 16, 2025, 22:13
John Oluwafemi Teibo: New Insights into CAR-T Molecular Effectors and Signaling Pathways
Voices
Aug 16, 2025, 21:51
Paolo Bossi: How to Intercept Malignant Transformation
Positive
Aug 16, 2025, 21:38
IASLC Congratulates Chelisa Cardinez on 2025 Early Career Grant Award
Voices
Aug 16, 2025, 21:17
Abdu Adem Yesufe: Radiotherapy Training in Dubai with Varian Oncology Systems and ELMED Medical Systems
Voices
Aug 16, 2025, 21:07
George Weiner: Press Forward - Advice to Early Career Researchers in Times of Uncertainty
Positive
Aug 16, 2025, 21:05
32 Million Cancer Survivors and Counting - UICC
Voices
Aug 16, 2025, 20:49
Register by August 18: AACR Special Conference on Cancer Immunity and Cancer-Related Autoimmunity
Insight
Aug 16, 2025, 20:40
Liang Cheng: Redefining Bladder Cancer Care with Urinary DNA Insights
Insight
Aug 16, 2025, 20:38
Eduardo Bruera: Why Do Argentinian Oncologists Refer Patients Late for Palliative Care?
Voices
Aug 16, 2025, 20:29
Rob Winn: From Leukemia Diagnosis to Remission and Advocacy
Societies
Aug 16, 2025, 20:27
The Faces of Discovery - Peter MacCallum Cancer Centre